Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2018-06-30
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment
NCT01520181
Inhibitory Receptors in Eosinophils of Atopic Subjects
NCT01489293
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
NCT00557895
Quality of Life in Systemic Nickel Allergy Syndrome
NCT03731494
The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department
NCT06823154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
patients with suscpition of a life threatening allergic reaction will be reffered to an allergy clinic for the challange test. the rest of the pateints will be given the test in the primary clinic: 1ml (50 grams) of amoxicillin, and an hour later a full dose of 500 mg amoxicillin.
after determining no allergic reaction develops the title will be erased from the medical record.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment
penicillin chalange test, as descibed.
Amoxicillin
chalange test of 50 mg, and after an hour 500 mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amoxicillin
chalange test of 50 mg, and after an hour 500 mg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
5 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clalit Health Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Lital Goldberg
dr lital goldberg
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
lital f goldberg, MD. MPH
Role: PRINCIPAL_INVESTIGATOR
Clalit Health Services
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0185-17-COM2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.